Compare FMC Corp (FMC) vs Lemonade Inc (LMND) Price & Performance

FMC trades at $9.09, up 0.66% with bearish technical signals despite recent earnings beats. The agricultural sciences company faces severe profitability challenges with a -84.83% net margin and negative ROE, though valuation ratios appear attractive with P/S of 0.35 and P/B of 0.86. Recent developments include regulatory filings for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.

While analyst consensus suggests moderate upside to the $14.60 price target, significant operational challenges and negative cash flow from operations in 2025 present substantial risks. The company's aggressive deleveraging efforts and new product pipeline offer potential catalysts, but investors face headwinds from cyclical industry pressures and persistent profitability issues.

Lemonade (LMND) trades at $46.83, up 1.14% with a bearish technical outlook despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Analyst sentiment is evenly split between buy/hold/sell with a $67 consensus target, while institutional activity shows mixed positioning. Recent expansion into Alaska and Kentucky renters insurance and pet insurance markets supports growth trajectory.

Lemonade's path to profitability remains the key investment thesis, targeting EBITDA positivity by late 2026. The stock offers growth potential through AI-driven efficiency and market expansion but carries significant execution risk amid persistent losses. Current valuation at 3.63x sales appears reasonable for the growth profile, though technical weakness near support at $45 requires monitoring.